Compare Organon & Co. Common Stock (OGN) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Williams-Sonoma, Inc. — how do they compare? Organon & Co. Common Stock trades at $13.77 (market cap $3.61B), while Williams-Sonoma, Inc. trades at $249.87 (market cap $28.26B). The key difference: Williams-Sonoma, Inc. is far larger — about 7.8× Organon & Co. Common Stock's market cap, and Williams-Sonoma, Inc. pays the higher dividend (1.27%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Williams-Sonoma, Inc. for 59 Days on average.
| OGN | WSM | |
|---|---|---|
Market Cap | $3.61B | $28.26B |
Volume | 1,808,049 | 1,108,410 |
Sector | Health | Consumer Cyclical |
52-Week High | $13.81 | $251.81 |
52-Week Low | $5.70 | $168.64 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $11.03B | $28.76B |
Dividend Yield | 0.58% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Williams-Sonoma (WSM) trades at $239.98, up 0.47% on the day, and shows a bullish technical trend with support at $236 and resistance at $243. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $2.10 surpassing the $2.08 estimate. Strong profitability is evident with a net income margin of 14.73% and ROE of 54.96%. Recent news highlights market share gains and margin expansion through reduced discounting.
The outlook for WSM is positive, supported by earnings momentum and strategic initiatives, but risks include housing market sensitivity and competitive pressures. The consensus price target of $246.31 suggests modest upside, with analysts predominantly holding a neutral stance. Investment opportunity lies in sustained operational efficiency, though macroeconomic headwinds remain a key watchpoint.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
